Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma

Tanaka,Noriyuki; Yoshida,Hiroshi; Suzuki,Yoshio; Harigaya,Kenichi

doi:10.3892/ijo.2014.2591

Relative expression of hMena11a and hMenaINV splice isoforms is a useful biomarker in development and progression of human breast carcinoma

Authors:
- Noriyuki Tanaka
- Hiroshi Yoshida
- Yoshio Suzuki
- Kenichi Harigaya
View Affiliations

Affiliations: Department of Molecular and Tumor Pathology, Chiba University Graduate School of Medicine, Chuo-ku, Chiba 260-8670, Japan, Department of Pathology, Asahi General Hospital, Chiba 289-2515, Japan
Published online on: August 8, 2014 https://doi.org/10.3892/ijo.2014.2591
Pages: 1921-1928

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Alternative splicing provides additional genomic complexity by producing multiple mRNAs and protein variants from any given gene. Splice variants have been identified in a large variety of cancer genes, suggesting that widespread aberrant and alternative splicing may be a consequence or even a cause of cancer. Human ortholog of mammalian enabled (hMena), a family of enabled/vasodilator-stimulated phosphoproteins (Ena/VASP), is an actin regulatory protein involved in the regulation of cell motility. hMena has been shown to have several splice variants, including the hMenaINV isoform, expressed in invasive cancer cells, and the epithelial-specific isoform, hMena11a. We assessed the relative mRNA expression of hMena splice variants in 50 cases of invasive ductal breast carcinoma of no special type (IDC-NST) and 45 cases of ductal breast carcinoma in situ (DCIS) with special reference to non-neoplastic breast epithelial tissues. The samples were dissected from their respective regions by laser microdissection. Our results confirmed previous reports that hMenaINV expression is augmented during tumor progression, while hMena11a is downregulated. Furthermore, simultaneous expression of hMena11a and hMenaINV was found only in malignant lesions, while their expression was hardly detected in normal breast tissue and benign proliferative breast lesions. These results indicate that the higher relative expression of hMena11a compared with hMenaINV may predict malignant transformation in breast epithelial cells, and, furthermore, a reversal of expression of hMena11a and hMenaINV may dictate the state of cancer progression. Here, we demonstrate that determination of hMena11a and hMenaINV expression could be a useful biomarker for predicting malignant behavior in breast epithelial lesions, and show that their relative expression is linked to adverse prognostic factors. Although the biological activity of the majority of alternatively spliced isoforms and their contribution to cancer biology has yet to be determined, their elucidation will have a large impact on therapeutic strategies for cancer.

View Figures

View References

1	DeSantis C, Ma J, Bryan L and Jemal A: Breast cancer statistics, 2013. CA Cancer J Clin. 64:52–62. 2014. View Article : Google Scholar
2	Matsuda A, Matsuda T, Shibata A, et al: Cancer incidence and incidence rates in Japan in 2008: a study of 25 population-based cancer registries for the Monitoring of Cancer Incidence in Japan (MCIJ) project. Jpn J Clin Oncol. 44:388–396. 2014. View Article : Google Scholar : PubMed/NCBI
3	Friedl P and Wolf K: Tumour-cell invasion and migration: diversity and escape mechanisms. Nat Rev Cancer. 3:362–374. 2003. View Article : Google Scholar : PubMed/NCBI
4	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar
5	Rybinski B, Franco-Barraza J and Cukierman E: The wound healing, chronic fibrosis and cancer progression triad. Physiol Genomics. 46:223–244. 2014. View Article : Google Scholar
6	Savagner P, Valles AM, Jouanneau J, Yamada KM and Thiery JP: Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Biol Cell. 5:851–862. 1994. View Article : Google Scholar
7	Warzecha CC, Sato TK, Nabet B, Hogenesch JB and Carstens RP: ESRP1 and ESRP2 are epithelial cell-type-specific regulators of FGFR2 splicing. Mol Cell. 33:591–601. 2009. View Article : Google Scholar : PubMed/NCBI
8	Shapiro IM, Cheng AW, Flytzanis NC, et al: An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet. 7:e10022182011. View Article : Google Scholar : PubMed/NCBI
9	Barzik M, Kotova TI, Higgs HN, et al: Ena/VASP proteins enhance actin polymerization in the presence of barbed end capping proteins. J Biol Chem. 280:28653–28662. 2005. View Article : Google Scholar : PubMed/NCBI
10	Bear JE, Svitkina TM, Krause M, et al: Antagonism between Ena/VASP proteins and actin filament capping regulates fibroblast motility. Cell. 109:509–521. 2002. View Article : Google Scholar : PubMed/NCBI
11	Gertler F and Condeelis J: Metastasis: tumor cells becoming MENAcing. Trends Cell Biol. 21:81–90. 2011. View Article : Google Scholar : PubMed/NCBI
12	Di Modugno F, DeMonte L, Balsamo M, et al: Molecular cloning of hMena (ENAH) and its splice variant hMena^+11a: epidermal growth factor increases their expression and stimulates hMena^+11a phosphorylation in breast cancer cell lines. Cancer Res. 67:2657–2665. 2007.PubMed/NCBI
13	Urbanelli L, Massini C, Emiliani C and Orlacchio A, Bernardi G and Orlacchio A: Characterization of human Enah gene. Biochim Biophys Acta. 1759:99–107. 2006. View Article : Google Scholar : PubMed/NCBI
14	Itakura M, Terashima Y, Shingyoji M, et al: High CC chemokine receptor 7 expression improves postoperative prognosis of lung adenocarcinoma patients. Br J Cancer. 109:1100–1108. 2013. View Article : Google Scholar : PubMed/NCBI
15	Monney L, Sabatos CA, Gaglia JL, et al: Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease. Nature. 415:536–541. 2002. View Article : Google Scholar : PubMed/NCBI
16	Ellis I and Simpson J: Grading. WHO Classification of Tumours of the Breast. Lakhani S, Ellis I and Schnitt S: IARC Press; Lyon: pp. 19–23. 2012
17	Ellis I, Collins L and Ichihara S: Invasive carcinoma of no special type. WHO Classification of Tumours of the Breast. Lakhani S, Ellis I and Schnitt S: IARC Press; Lyon: pp. 34–38. 2012
18	Goswami S, Philippar U, Sun D, et al: Identification of invasion specific splice variants of the cytoskeletal protein Mena present in mammary tumor cells during invasion in vivo. Clin Exp Metastasis. 26:153–159. 2009. View Article : Google Scholar : PubMed/NCBI
19	Philippar U, Roussos ET, Oser M, et al: A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis. Dev Cell. 15:813–828. 2008. View Article : Google Scholar : PubMed/NCBI
20	Pino MS, Balsamo M, Di Modugno F, et al: Human Mena^+11a isoform serves as a marker of epithelial phenotype and sensitivity to epidermal growth factor receptor inhibition in human pancreatic cancer cell lines. Clin Cancer Res. 14:4943–4950. 2008.PubMed/NCBI
21	Agarwal S, Gertler FB, Balsamo M, et al: Quantitative assessment of invasive mena isoforms (Menacalc) as an independent prognostic marker in breast cancer. Breast Cancer Res. 14:R1242012. View Article : Google Scholar : PubMed/NCBI
22	Wapnir IL, Dignam JJ, Fisher B, et al: Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J Natl Cancer Inst. 103:478–488. 2011. View Article : Google Scholar
23	Roussos ET, Balsamo M, Alford SK, et al: Mena invasive (Mena^INV) promotes multicellular streaming motility and transendothelial migration in a mouse model of breast cancer. J Cell Sci. 124:2120–2131. 2011.PubMed/NCBI
24	Roussos ET, Goswami S, Balsamo M, et al: Mena invasive (Mena^INV) and Mena^11a isoforms play distinct roles in breast cancer cell cohesion and association with TMEM. Clin Exp Metastasis. 28:515–527. 2011.PubMed/NCBI
25	Warzecha CC and Carstens RP: Complex changes in alternative pre-mRNA splicing play a central role in the epithelial-to-mesenchymal transition (EMT). Semin Cancer Biol. 22:417–427. 2012. View Article : Google Scholar : PubMed/NCBI